“The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained

Cannabis, as a natural medicinal remedy, has long been used for palliative treatment to alleviate the side effects caused by diseases. Cannabis-based products isolated from plant extracts exhibit potent immunoregulatory properties, reducing chronic inflammatory processes and providing much needed pa...

Full description

Bibliographic Details
Main Authors: Mona Khoury, Idan Cohen, Gil Bar-Sela
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/14/2/389
_version_ 1797477215854657536
author Mona Khoury
Idan Cohen
Gil Bar-Sela
author_facet Mona Khoury
Idan Cohen
Gil Bar-Sela
author_sort Mona Khoury
collection DOAJ
description Cannabis, as a natural medicinal remedy, has long been used for palliative treatment to alleviate the side effects caused by diseases. Cannabis-based products isolated from plant extracts exhibit potent immunoregulatory properties, reducing chronic inflammatory processes and providing much needed pain relief. They are a proven effective solution for treatment-based side effects, easing the resulting symptoms of the disease. However, we discuss the fact that cannabis use may promote the progression of a range of malignancies, interfere with anti-cancer immunotherapy, or increase susceptibility to viral infections and transmission. Most cannabis preparations or isolated active components cause an overall potent immunosuppressive impact among users, posing a considerable hazard to patients with suppressed or compromised immune systems. In this review, current knowledge and perceptions of cannabis or cannabinoids and their impact on various immune-system components will be discussed as the “two sides of the same coin” or “double-edged sword”, referring to something that can have both favorable and unfavorable consequences. We propose that much is still unknown about adverse reactions to its use, and its integration with medical treatment should be conducted cautiously with consideration of the individual patient, effector cells, microenvironment, and the immune system.
first_indexed 2024-03-09T21:14:30Z
format Article
id doaj.art-ee30ad5e16454736ad949e300b605963
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-09T21:14:30Z
publishDate 2022-02-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-ee30ad5e16454736ad949e300b6059632023-11-23T21:38:34ZengMDPI AGPharmaceutics1999-49232022-02-0114238910.3390/pharmaceutics14020389“The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons ExplainedMona Khoury0Idan Cohen1Gil Bar-Sela2Cancer Center, Emek Medical Center, 21 Yitzhak Rabin Blvd, Afula 1834111, IsraelCancer Center, Emek Medical Center, 21 Yitzhak Rabin Blvd, Afula 1834111, IsraelCancer Center, Emek Medical Center, 21 Yitzhak Rabin Blvd, Afula 1834111, IsraelCannabis, as a natural medicinal remedy, has long been used for palliative treatment to alleviate the side effects caused by diseases. Cannabis-based products isolated from plant extracts exhibit potent immunoregulatory properties, reducing chronic inflammatory processes and providing much needed pain relief. They are a proven effective solution for treatment-based side effects, easing the resulting symptoms of the disease. However, we discuss the fact that cannabis use may promote the progression of a range of malignancies, interfere with anti-cancer immunotherapy, or increase susceptibility to viral infections and transmission. Most cannabis preparations or isolated active components cause an overall potent immunosuppressive impact among users, posing a considerable hazard to patients with suppressed or compromised immune systems. In this review, current knowledge and perceptions of cannabis or cannabinoids and their impact on various immune-system components will be discussed as the “two sides of the same coin” or “double-edged sword”, referring to something that can have both favorable and unfavorable consequences. We propose that much is still unknown about adverse reactions to its use, and its integration with medical treatment should be conducted cautiously with consideration of the individual patient, effector cells, microenvironment, and the immune system.https://www.mdpi.com/1999-4923/14/2/389medical cannabisendocannabinoidsphytocannabinoids
spellingShingle Mona Khoury
Idan Cohen
Gil Bar-Sela
“The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained
Pharmaceutics
medical cannabis
endocannabinoids
phytocannabinoids
title “The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained
title_full “The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained
title_fullStr “The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained
title_full_unstemmed “The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained
title_short “The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained
title_sort the two sides of the same coin medical cannabis cannabinoids and immunity pros and cons explained
topic medical cannabis
endocannabinoids
phytocannabinoids
url https://www.mdpi.com/1999-4923/14/2/389
work_keys_str_mv AT monakhoury thetwosidesofthesamecoinmedicalcannabiscannabinoidsandimmunityprosandconsexplained
AT idancohen thetwosidesofthesamecoinmedicalcannabiscannabinoidsandimmunityprosandconsexplained
AT gilbarsela thetwosidesofthesamecoinmedicalcannabiscannabinoidsandimmunityprosandconsexplained